Health

Medicinal chemist John Tucker, PhD, and hypertension specialist Swapnil Hiremath, MD, share their perspectives and impressions on the unsettling question of generic drugs.

In a sense, it is hardly surprising that so little attention has been paid to scandals within universal healthcare systems given the histories of underperformance, scandal, and perpetual crisis associated with many such systems.

Generic drug use has been encouraged through decades of favorable legislation and subsidies. What should doctors and the public know about generic drug manufacture?

A health policy of choice—not of constraints—is what we need, says guest David Balat.

What is the outlook for the science of mental illness and the practice of psychiatry? Accad and Koka interview Dr. George Dawson.

Bob Murphy and longtime libertarian journalist Bretigne Shaffer discuss the vaccinations now enforced for school children in California, and the parents who are protesting the policy.

Peter Klein discusses “evidence-based economics” and the relative place of randomized trials in economics and medicine.

Do hospital-based physicians benefit from being out-of-network? Are policy wonks who attack “surprise billing” fully aware of the relevant factors?

Accad and Koka interview Dr. Cecile Janssens, whose research concerns the translation of genomics research to applications in clinical and public health practice.